ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Inflammatory Bowel Disease (IBD) Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-5Z14390
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Inflammatory Bowel Disease IBD Drugs Market Research Report 2023
BUY CHAPTERS

Global Inflammatory Bowel Disease (IBD) Drugs Market Research Report 2025

Code: QYRE-Auto-5Z14390
Report
May 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
Biocon Ltd.
Johnson and Johnson
Novartis
Pfizer Inc
Quest Medical
Sanofi
Takeda Pharmaceutical
UCB Pharma
AbbVie
Zhejiang Hisun Pharmaceutical Co Ltd
North China Pharmaceutical Co., Ltd
Huadong Medicine Co.,Ltd
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Zhejiang Zhebei Pharmaceutical Co., Ltd.
Heilongjiang Tianhong Pharmaceutical Co., Ltd.

Inflammatory Bowel Disease (IBD) Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Inflammatory Bowel Disease (IBD) Drugs Market

Inflammatory Bowel Disease (IBD) Drugs Market

The global market for Inflammatory Bowel Disease (IBD) Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Inflammatory Bowel Disease (IBD) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inflammatory Bowel Disease (IBD) Drugs.
The Inflammatory Bowel Disease (IBD) Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inflammatory Bowel Disease (IBD) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inflammatory Bowel Disease (IBD) Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Inflammatory Bowel Disease (IBD) Drugs Market Report

Report Metric Details
Report Name Inflammatory Bowel Disease (IBD) Drugs Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Biocon Ltd, Johnson and Johnson, Novartis AG, Pfizer, Quest Medical, Sanofi, Takeda Pharmaceutical, UCB Pharma, AbbVie, Zhejiang Hisun Pharmaceutical Co.,Ltd., North China Pharmaceutical Co., Ltd., Zhejiang Zhebei Pharmaceutical Co., Ltd., Huadong Medicine Co., Ltd., Shenzhen Salubris Pharmaceuticals Co.,Ltd., Heilongjiang Tianhong Pharmaceutical Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Inflammatory Bowel Disease (IBD) Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Inflammatory Bowel Disease (IBD) Drugs Market report?

Ans: The main players in the Inflammatory Bowel Disease (IBD) Drugs Market are Abbott Laboratories, Biocon Ltd, Johnson and Johnson, Novartis AG, Pfizer, Quest Medical, Sanofi, Takeda Pharmaceutical, UCB Pharma, AbbVie, Zhejiang Hisun Pharmaceutical Co.,Ltd., North China Pharmaceutical Co., Ltd., Zhejiang Zhebei Pharmaceutical Co., Ltd., Huadong Medicine Co., Ltd., Shenzhen Salubris Pharmaceuticals Co.,Ltd., Heilongjiang Tianhong Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Inflammatory Bowel Disease (IBD) Drugs Market report?

Ans: The Applications covered in the Inflammatory Bowel Disease (IBD) Drugs Market report are Ulceratory Colitis, Crohn's Disease

What are the Type segmentation covered in the Inflammatory Bowel Disease (IBD) Drugs Market report?

Ans: The Types covered in the Inflammatory Bowel Disease (IBD) Drugs Market report are Aminosalicylate, Corticosteroid Hormone, Immunosuppressants, Biological Agents

Recommended Reports

Digestive Disease Drugs

Anti-inflammatory Drugs

Pharmaceutical Market Trends

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Aminosalicylate
1.2.3 Corticosteroid Hormone
1.2.4 Immunosuppressants
1.2.5 Biological Agents
1.3 Market by Application
1.3.1 Global Inflammatory Bowel Disease (IBD) Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Ulceratory Colitis
1.3.3 Crohn's Disease
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inflammatory Bowel Disease (IBD) Drugs Market Perspective (2020-2031)
2.2 Global Inflammatory Bowel Disease (IBD) Drugs Growth Trends by Region
2.2.1 Global Inflammatory Bowel Disease (IBD) Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Inflammatory Bowel Disease (IBD) Drugs Historic Market Size by Region (2020-2025)
2.2.3 Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Region (2026-2031)
2.3 Inflammatory Bowel Disease (IBD) Drugs Market Dynamics
2.3.1 Inflammatory Bowel Disease (IBD) Drugs Industry Trends
2.3.2 Inflammatory Bowel Disease (IBD) Drugs Market Drivers
2.3.3 Inflammatory Bowel Disease (IBD) Drugs Market Challenges
2.3.4 Inflammatory Bowel Disease (IBD) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inflammatory Bowel Disease (IBD) Drugs Players by Revenue
3.1.1 Global Top Inflammatory Bowel Disease (IBD) Drugs Players by Revenue (2020-2025)
3.1.2 Global Inflammatory Bowel Disease (IBD) Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Inflammatory Bowel Disease (IBD) Drugs Revenue
3.4 Global Inflammatory Bowel Disease (IBD) Drugs Market Concentration Ratio
3.4.1 Global Inflammatory Bowel Disease (IBD) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease (IBD) Drugs Revenue in 2024
3.5 Global Key Players of Inflammatory Bowel Disease (IBD) Drugs Head office and Area Served
3.6 Global Key Players of Inflammatory Bowel Disease (IBD) Drugs, Product and Application
3.7 Global Key Players of Inflammatory Bowel Disease (IBD) Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Inflammatory Bowel Disease (IBD) Drugs Breakdown Data by Type
4.1 Global Inflammatory Bowel Disease (IBD) Drugs Historic Market Size by Type (2020-2025)
4.2 Global Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Type (2026-2031)
5 Inflammatory Bowel Disease (IBD) Drugs Breakdown Data by Application
5.1 Global Inflammatory Bowel Disease (IBD) Drugs Historic Market Size by Application (2020-2025)
5.2 Global Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Inflammatory Bowel Disease (IBD) Drugs Market Size (2020-2031)
6.2 North America Inflammatory Bowel Disease (IBD) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2020-2025)
6.4 North America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Inflammatory Bowel Disease (IBD) Drugs Market Size (2020-2031)
7.2 Europe Inflammatory Bowel Disease (IBD) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2020-2025)
7.4 Europe Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size (2020-2031)
8.2 Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size (2020-2031)
9.2 Latin America Inflammatory Bowel Disease (IBD) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2020-2025)
9.4 Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size (2020-2031)
10.2 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Inflammatory Bowel Disease (IBD) Drugs Introduction
11.1.4 Abbott Laboratories Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Biocon Ltd
11.2.1 Biocon Ltd Company Details
11.2.2 Biocon Ltd Business Overview
11.2.3 Biocon Ltd Inflammatory Bowel Disease (IBD) Drugs Introduction
11.2.4 Biocon Ltd Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
11.2.5 Biocon Ltd Recent Development
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Company Details
11.3.2 Johnson and Johnson Business Overview
11.3.3 Johnson and Johnson Inflammatory Bowel Disease (IBD) Drugs Introduction
11.3.4 Johnson and Johnson Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
11.3.5 Johnson and Johnson Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Inflammatory Bowel Disease (IBD) Drugs Introduction
11.4.4 Novartis AG Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
11.4.5 Novartis AG Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Inflammatory Bowel Disease (IBD) Drugs Introduction
11.5.4 Pfizer Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Quest Medical
11.6.1 Quest Medical Company Details
11.6.2 Quest Medical Business Overview
11.6.3 Quest Medical Inflammatory Bowel Disease (IBD) Drugs Introduction
11.6.4 Quest Medical Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
11.6.5 Quest Medical Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Inflammatory Bowel Disease (IBD) Drugs Introduction
11.7.4 Sanofi Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
11.7.5 Sanofi Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Details
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Drugs Introduction
11.8.4 Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
11.8.5 Takeda Pharmaceutical Recent Development
11.9 UCB Pharma
11.9.1 UCB Pharma Company Details
11.9.2 UCB Pharma Business Overview
11.9.3 UCB Pharma Inflammatory Bowel Disease (IBD) Drugs Introduction
11.9.4 UCB Pharma Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
11.9.5 UCB Pharma Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Details
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Inflammatory Bowel Disease (IBD) Drugs Introduction
11.10.4 AbbVie Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
11.10.5 AbbVie Recent Development
11.11 Zhejiang Hisun Pharmaceutical Co.,Ltd.
11.11.1 Zhejiang Hisun Pharmaceutical Co.,Ltd. Company Details
11.11.2 Zhejiang Hisun Pharmaceutical Co.,Ltd. Business Overview
11.11.3 Zhejiang Hisun Pharmaceutical Co.,Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.11.4 Zhejiang Hisun Pharmaceutical Co.,Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
11.11.5 Zhejiang Hisun Pharmaceutical Co.,Ltd. Recent Development
11.12 North China Pharmaceutical Co., Ltd.
11.12.1 North China Pharmaceutical Co., Ltd. Company Details
11.12.2 North China Pharmaceutical Co., Ltd. Business Overview
11.12.3 North China Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.12.4 North China Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
11.12.5 North China Pharmaceutical Co., Ltd. Recent Development
11.13 Zhejiang Zhebei Pharmaceutical Co., Ltd.
11.13.1 Zhejiang Zhebei Pharmaceutical Co., Ltd. Company Details
11.13.2 Zhejiang Zhebei Pharmaceutical Co., Ltd. Business Overview
11.13.3 Zhejiang Zhebei Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.13.4 Zhejiang Zhebei Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
11.13.5 Zhejiang Zhebei Pharmaceutical Co., Ltd. Recent Development
11.14 Huadong Medicine Co., Ltd.
11.14.1 Huadong Medicine Co., Ltd. Company Details
11.14.2 Huadong Medicine Co., Ltd. Business Overview
11.14.3 Huadong Medicine Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.14.4 Huadong Medicine Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
11.14.5 Huadong Medicine Co., Ltd. Recent Development
11.15 Shenzhen Salubris Pharmaceuticals Co.,Ltd.
11.15.1 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Company Details
11.15.2 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Business Overview
11.15.3 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.15.4 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
11.15.5 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Recent Development
11.16 Heilongjiang Tianhong Pharmaceutical Co., Ltd.
11.16.1 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Details
11.16.2 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Business Overview
11.16.3 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.16.4 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
11.16.5 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abbott Laboratories
Biocon Ltd.
Johnson and Johnson
Novartis
Pfizer Inc
Quest Medical
Sanofi
Takeda Pharmaceutical
UCB Pharma
AbbVie
Zhejiang Hisun Pharmaceutical Co Ltd
North China Pharmaceutical Co., Ltd
Huadong Medicine Co.,Ltd
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Zhejiang Zhebei Pharmaceutical Co., Ltd.
Heilongjiang Tianhong Pharmaceutical Co., Ltd.
List of Tables
 Table 1. Global Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Aminosalicylate
 Table 3. Key Players of Corticosteroid Hormone
 Table 4. Key Players of Immunosuppressants
 Table 5. Key Players of Biological Agents
 Table 6. Global Inflammatory Bowel Disease (IBD) Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Region (2020-2025)
 Table 10. Global Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Region (2026-2031)
 Table 12. Inflammatory Bowel Disease (IBD) Drugs Market Trends
 Table 13. Inflammatory Bowel Disease (IBD) Drugs Market Drivers
 Table 14. Inflammatory Bowel Disease (IBD) Drugs Market Challenges
 Table 15. Inflammatory Bowel Disease (IBD) Drugs Market Restraints
 Table 16. Global Inflammatory Bowel Disease (IBD) Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Players (2020-2025)
 Table 18. Global Top Inflammatory Bowel Disease (IBD) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease (IBD) Drugs as of 2024)
 Table 19. Ranking of Global Top Inflammatory Bowel Disease (IBD) Drugs Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Inflammatory Bowel Disease (IBD) Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Inflammatory Bowel Disease (IBD) Drugs, Headquarters and Area Served
 Table 22. Global Key Players of Inflammatory Bowel Disease (IBD) Drugs, Product and Application
 Table 23. Global Key Players of Inflammatory Bowel Disease (IBD) Drugs, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Inflammatory Bowel Disease (IBD) Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Inflammatory Bowel Disease (IBD) Drugs Revenue Market Share by Type (2020-2025)
 Table 27. Global Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Inflammatory Bowel Disease (IBD) Drugs Revenue Market Share by Type (2026-2031)
 Table 29. Global Inflammatory Bowel Disease (IBD) Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Inflammatory Bowel Disease (IBD) Drugs Revenue Market Share by Application (2020-2025)
 Table 31. Global Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Inflammatory Bowel Disease (IBD) Drugs Revenue Market Share by Application (2026-2031)
 Table 33. North America Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Abbott Laboratories Company Details
 Table 49. Abbott Laboratories Business Overview
 Table 50. Abbott Laboratories Inflammatory Bowel Disease (IBD) Drugs Product
 Table 51. Abbott Laboratories Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025) & (US$ Million)
 Table 52. Abbott Laboratories Recent Development
 Table 53. Biocon Ltd Company Details
 Table 54. Biocon Ltd Business Overview
 Table 55. Biocon Ltd Inflammatory Bowel Disease (IBD) Drugs Product
 Table 56. Biocon Ltd Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025) & (US$ Million)
 Table 57. Biocon Ltd Recent Development
 Table 58. Johnson and Johnson Company Details
 Table 59. Johnson and Johnson Business Overview
 Table 60. Johnson and Johnson Inflammatory Bowel Disease (IBD) Drugs Product
 Table 61. Johnson and Johnson Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025) & (US$ Million)
 Table 62. Johnson and Johnson Recent Development
 Table 63. Novartis AG Company Details
 Table 64. Novartis AG Business Overview
 Table 65. Novartis AG Inflammatory Bowel Disease (IBD) Drugs Product
 Table 66. Novartis AG Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025) & (US$ Million)
 Table 67. Novartis AG Recent Development
 Table 68. Pfizer Company Details
 Table 69. Pfizer Business Overview
 Table 70. Pfizer Inflammatory Bowel Disease (IBD) Drugs Product
 Table 71. Pfizer Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025) & (US$ Million)
 Table 72. Pfizer Recent Development
 Table 73. Quest Medical Company Details
 Table 74. Quest Medical Business Overview
 Table 75. Quest Medical Inflammatory Bowel Disease (IBD) Drugs Product
 Table 76. Quest Medical Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025) & (US$ Million)
 Table 77. Quest Medical Recent Development
 Table 78. Sanofi Company Details
 Table 79. Sanofi Business Overview
 Table 80. Sanofi Inflammatory Bowel Disease (IBD) Drugs Product
 Table 81. Sanofi Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025) & (US$ Million)
 Table 82. Sanofi Recent Development
 Table 83. Takeda Pharmaceutical Company Details
 Table 84. Takeda Pharmaceutical Business Overview
 Table 85. Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Drugs Product
 Table 86. Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025) & (US$ Million)
 Table 87. Takeda Pharmaceutical Recent Development
 Table 88. UCB Pharma Company Details
 Table 89. UCB Pharma Business Overview
 Table 90. UCB Pharma Inflammatory Bowel Disease (IBD) Drugs Product
 Table 91. UCB Pharma Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025) & (US$ Million)
 Table 92. UCB Pharma Recent Development
 Table 93. AbbVie Company Details
 Table 94. AbbVie Business Overview
 Table 95. AbbVie Inflammatory Bowel Disease (IBD) Drugs Product
 Table 96. AbbVie Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025) & (US$ Million)
 Table 97. AbbVie Recent Development
 Table 98. Zhejiang Hisun Pharmaceutical Co.,Ltd. Company Details
 Table 99. Zhejiang Hisun Pharmaceutical Co.,Ltd. Business Overview
 Table 100. Zhejiang Hisun Pharmaceutical Co.,Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
 Table 101. Zhejiang Hisun Pharmaceutical Co.,Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025) & (US$ Million)
 Table 102. Zhejiang Hisun Pharmaceutical Co.,Ltd. Recent Development
 Table 103. North China Pharmaceutical Co., Ltd. Company Details
 Table 104. North China Pharmaceutical Co., Ltd. Business Overview
 Table 105. North China Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
 Table 106. North China Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025) & (US$ Million)
 Table 107. North China Pharmaceutical Co., Ltd. Recent Development
 Table 108. Zhejiang Zhebei Pharmaceutical Co., Ltd. Company Details
 Table 109. Zhejiang Zhebei Pharmaceutical Co., Ltd. Business Overview
 Table 110. Zhejiang Zhebei Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
 Table 111. Zhejiang Zhebei Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025) & (US$ Million)
 Table 112. Zhejiang Zhebei Pharmaceutical Co., Ltd. Recent Development
 Table 113. Huadong Medicine Co., Ltd. Company Details
 Table 114. Huadong Medicine Co., Ltd. Business Overview
 Table 115. Huadong Medicine Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
 Table 116. Huadong Medicine Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025) & (US$ Million)
 Table 117. Huadong Medicine Co., Ltd. Recent Development
 Table 118. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Company Details
 Table 119. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Business Overview
 Table 120. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
 Table 121. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025) & (US$ Million)
 Table 122. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Recent Development
 Table 123. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Details
 Table 124. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Business Overview
 Table 125. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
 Table 126. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025) & (US$ Million)
 Table 127. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Development
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Inflammatory Bowel Disease (IBD) Drugs Picture
 Figure 2. Global Inflammatory Bowel Disease (IBD) Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Aminosalicylate Features
 Figure 5. Corticosteroid Hormone Features
 Figure 6. Immunosuppressants Features
 Figure 7. Biological Agents Features
 Figure 8. Global Inflammatory Bowel Disease (IBD) Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Application: 2024 VS 2031
 Figure 10. Ulceratory Colitis Case Studies
 Figure 11. Crohn's Disease Case Studies
 Figure 12. Inflammatory Bowel Disease (IBD) Drugs Report Years Considered
 Figure 13. Global Inflammatory Bowel Disease (IBD) Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Inflammatory Bowel Disease (IBD) Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Region: 2024 VS 2031
 Figure 16. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Players in 2024
 Figure 17. Global Top Inflammatory Bowel Disease (IBD) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease (IBD) Drugs as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease (IBD) Drugs Revenue in 2024
 Figure 19. North America Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Inflammatory Bowel Disease (IBD) Drugs Market Share by Country (2020-2031)
 Figure 21. United States Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Inflammatory Bowel Disease (IBD) Drugs Market Share by Country (2020-2031)
 Figure 25. Germany Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Share by Region (2020-2031)
 Figure 33. China Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Inflammatory Bowel Disease (IBD) Drugs Market Share by Country (2020-2031)
 Figure 41. Mexico Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Share by Country (2020-2031)
 Figure 45. Turkey Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Abbott Laboratories Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
 Figure 49. Biocon Ltd Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
 Figure 50. Johnson and Johnson Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
 Figure 51. Novartis AG Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
 Figure 52. Pfizer Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
 Figure 53. Quest Medical Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
 Figure 54. Sanofi Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
 Figure 55. Takeda Pharmaceutical Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
 Figure 56. UCB Pharma Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
 Figure 57. AbbVie Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
 Figure 58. Zhejiang Hisun Pharmaceutical Co.,Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
 Figure 59. North China Pharmaceutical Co., Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
 Figure 60. Zhejiang Zhebei Pharmaceutical Co., Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
 Figure 61. Huadong Medicine Co., Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
 Figure 62. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
 Figure 63. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Inflammatory Bowel Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inflammatory Bowel Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global IBD Ulcerative Colitis and Crohn s Disease Treatment Market Insights Forecast to 2030
Global Crohn s Disease Drug Market Research Report 2024
Global Ulcerative Colitis Medicine Market Research Report 2025
Global Crohn s Disease Treatment Drug Market Research Report 2025
Global Ulcerative Colitis Immunology Drugs Market Research Report 2024
Global Ulcerative Colitis Treatment Options Market Research Report 2025
Chronic Intestinal Inflammation Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Uveitis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autoimmune Diseases Treatment Market Research Report 2024
Chronic Metabolic Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Still s Disease Treatment Market Research Report 2025
Global Peptic Ulcers Treatment Market Research Report 2024
Infectious Enteritis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bulk Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Colon Targeting Drug Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Colonoscopy Bowel Preparation Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions